Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |